COVID -19 Impact on the Preparative and Process Chromatography Market
The COVID-19 pandemic has significantly affected the preparative and process chromatography market. With the increasing threat associated with COVID, researchers are highly dependent on analytical laboratory techniques such as chromatography to gain effective and efficient methods for characterizing the virus and analyze potential vaccines and anti-COVID-19 compounds.
As the battle against the deadly SARS-CoV-2 virus continues, researchers rely on analytical laboratory techniques like chromatography to provide effective and efficient methods for characterizing the virus and analyzing potential vaccines and anti-COVID-19 compounds.
Increasing demand for insulin and other biopharmaceutical products, high demand for omega-3 fatty acids, increasing awareness about the advancements in preparative and process chromatography, increasing food safety concerns.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151748164
[330 Pages Report] The preparative and process chromatography market is projected to reach USD 12.8 billion by 2026 from USD 9.3 billion in 2021, at a CAGR of 6.7% from 2021 to 2026.
Preparative and process chromatography systems are priced at a premium because of the features and technologies involved. Small- & medium-sized companies in the oil & gas, food & beverage, biotech & pharmaceutical industries, and research and academic institutions require many such systems in their processes.
Due to the high costs involved and the budget constraints of many academic institutions, preparative and process chromatography products are witnessing limited adoption. Moreover, pharmaceutical companies currently using preparative and process chromatography are reluctant to invest in new instruments.
Preparative and process chromatography plays a vital role in purifying monoclonal antibodies (mAbs). mAbs showcase enormous potential as biopharmaceuticals to treat a wide range of diseases.
The major players operating in this market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Waters Corporation (France), Novasep Holding S.A.S. (France), Daicel Corporation (Japan), PerkinElmer, Inc. (US), Hitachi High-Tech Corporation (Japan), GL Sciences, Inc. (Japan), Sartorius AG (Germany).